A strategy for designing error detection schemes for general datanetworks

The author presents a five-step methodology that provides insight into the order in which errors should be considered when designing an error detection scheme, which types of error detection mechanisms are most effective, and which layer should be responsible for detecting a given type of error     

ATM switching and CPE adaptation in the North Carolina InformationHighway

This article describes the approach which has been used to implement a sector of the information highway throughout the state of North Carolina, with specific attention focused on the functionality of the equipment that comprises the North Carolina Information Highway (NCIH). This implementation of this information highway is based on ATM technology, used in both the switching systems of the network and the customer premises equipment (CPE). The large ATM switching systems provide the extensive number of connections that are predicted for the information highway. Multiple services can also be supported on the ATM switches. The information streams for these different services can all be converted into ATM format using the appropriate ATM adaptation layer for transport through the ATM network. By being able to support multiple services, and transport them across common ATM facilities, the ATM switches offer the NCIH great flexibility in the applications that can be provided to the customers. Use of the ATM technology allows the NCIH to provide the backbone for various services. To provide the distance learning service application and other applications on the NCIH, ATM capabilities are also being provided in CPE on a service multiplexer     

Models of visual word recognition: Sampling the state of the art.

A classification of models of visual word recognition is presented that facilitates formal comparisons between models of different formats. In light of the theoretical contributions to this special section, sets of criteria for the evaluation of models and strategies for model construction are discussed. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Data to frequency mappings in various MSK schemes

Minimum shift keying (MSK) is a digital modulation scheme which is suited to demanding applications requiring good bandwidth efficiency and error performance. It can be regarded as continuous phase frequency shift keying (CPFSK) with two signalling frequencies. In general, there is no unique mapping from the input data polarity to the particular signalling frequency during a given bit interval. The simplest formulation maps zeros of the data (marks) to the lower frequency, and ones (spaces) to the higher frequency. Other formulations of MSK employ more complex mappings. The article summarises the most commonly encountered mappings, then shows how to convert from one formulation to another by manipulating the input or output data. It is, therefore, possible to establish communication between different MSK modems employing different formulations of MSK by simple processing of the data     

The flagship is dropping behind the fleet [UK telecommunicationindustry]

Following privatisation in 1984, BT was mainly preoccupied with customer service, operating costs and business exploitation. BT, its competitors and the industry regulators now have to address major new network issues. Their success in meeting the challenges of the new technologies will have a major impact on the future of UK telecommunications equipment manufacturers. The author takes a hard look at the facts. He argues that duplicating local telecommunications plant is a mistake and should stop; price cap regulation produces the wrong result; and an authoritative engineering agency is needed to co-ordinate technology nationally     

Uniplanar techniques for monolithic microwave integrated circuits

`Uniplanar' techniques have recently been introduced for the design of monolithic microwave integrated circuits (MMICs). The aim of these techniques is to achieve a higher level of integration of circuitry and to overcome the need for through-substrate via holes and the related back-face processing steps. This is achieved by using coplanar waveguide (CPW), slotline, and miniature `thin-film microstrip' transmission-line media as opposed to conventional microstrip. The design and performance of a number of uniplanar MMIC couplers, amplifiers, and other test circuits fabricated using the GEC-Marconi (Caswell) foundry are described     

Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group

26 previously treated patients with progressive recurrent small cell lung cancer (SCLC) were given vinorelbine (Navelbine), 30 mg/m2 weekly. All patients had responded to first-line chemotherapy and were off therapy for at least 3 months. Partial response was observed in 4 out of 25 eligible patients (16%; 95% confidence interval 4-36%), stable disease in 7 patients and progression in 12 patients. The limiting toxicity was a non-cumulative leucopenia (80%, 32% WHO grade 3-4). Reaction at the site of injection was observed in 5 patients, causing treatment discontinuation in 2 cases. Other non-haematological toxicities were moderate. These results suggest acceptable toxicity and some antitumour activity of vinorelbine in pretreated SCLC patients.     

Thrombolytic therapy for unstable angina

Thrombolytic therapy for unstable angina has not gained acceptance as a primary treatment for unstable angina (UA) despite the evidence showing a reduction in mortality when these agents are given for myocardial infarction. The purpose of this review is to examine the clinical value of thrombolytic therapy for UA. The multiple lines of evidence supporting intracoronary thrombus formation as a key mechanism in the pathogenesis of UA are reviewed. Studies examining the effect of thrombolytic therapy on angiographic endpoints have shown little effect on the extent of luminal narrowing, but do reveal a decrease in angiographically detected thrombus. Twelve randomized, controlled trials of thrombolytic agents in 611 UA patients with predefined clinical endpoints have been published. These trials varied widely in design and adjunctive therapy both in treated and control grops. Review of these trials show a tendency to fewer clinical events such as death, infarction, and need for revascularization in treated patients, with a corresponding increase in bleeding complications. Clinical efficacy of thrombolytic therapy cannot be excluded by the available data, perhaps in part because of insufficient numbers of patients treated. Determination of the net clinical value of thrombolytic therapy must await larger and more definitive trials.